Combinations of pembrolizumab and targeted therapies for advanced clear cell kidney cancer
The KEYMAKER-U03 study is looking at different combinations of immunotherapy [...]
The KEYMAKER-U03 study is looking at different combinations of immunotherapy [...]
The treatment of heavily pretreated patients with metastatic kidney cancer [...]
The final survival information from the phase 3 CLEAR study [...]
In 2009, Cesar Fuentes was first diagnosed with kidney cancer [...]
Immunotherapy combinations are becoming the standard treatment for people with [...]
Immunotherapy combinations are becoming the standard treatment after surgery for [...]
Further follow-up data from the phase 3 CLEAR study with [...]
Lenvatinib plus pembrolizumab has already been shown to improve survival [...]
The National Institute for Health and Care Excellence (NICE) has [...]
The phase 2 KEYNOTE-B61 study was presented at the recent [...]